Lumexa Imaging Announces Fourth Quarter and Full Year 2025 Results, Reiterates Full Year 2026 Guidance
Lumexa Imaging announced robust preliminary financial results for Q4 and full year 2025, highlighted by revenue growth, improved adjusted EBITDA and margin expansion driven by advanced imaging volumes, new center openings, and key payer network returns. The company also reiterated its full-year 2026 guidance with expectations of continued growth an…